Available within our comprehensive immuno-oncology assay portfolio, Q2
Solutions’ MSI assay utilizes multiplex, fluorescent PCR and capillary electrophoresis to enable sensitive detection of five mononucleotide repeat markers (BAT-25, BAT-26, NR-21,
NR-24 and MONO-27) in tumor FFPE specimens. Microsatellite instability at two or more mononucleotide loci is interpreted as MSI-High; microsatellite instability at a single mononucleotide locus is interpreted as MSI-Low; no instability at any of the loci tested is interpreted
as microsatellite stable (MSS). The MSI assay has been analytically validated and is available for Research Use Only applications.
Download our factsheet to learn more about our MSI assay specifications.